Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-09-10FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for XTANDI (enzalutamide) from Astellas Pharma US, Inc. This approval updates the product labeling/i…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients [Phase 1]
This Phase 1 study assesses the relative bioavailability of enzalutamide in patients with prostate cancer and the trial is completed.
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy [Phase 2]
A Phase 2 trial of itraconazole in castration-resistant prostate cancer after chemotherapy was terminated, with results posted in 2014.
-
CLINICAL_TRIALS research · 2014-09-08Clinical Trial Update: MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance [Phase 1]
A Phase 1 clinical trial update investigating MRI/ultrasound fusion with contrast-enhanced ultrasound guidance for prostate cancer (prostati…
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer [Phase 3]
Phase 3 clinical trial results update on intermittent degarelix treatment for prostate cancer; the study is completed and results have been …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Prostate Cancer Antigen 3 (PCA-3) Gene Project [NA]
Clinical trial update notes a completed study involving the PCA-3 gene project related to prostate cancer and benign prostatic hyperplasia. …
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer [Phase 1, Phase 2]
This clinical trial update reports results from a phase 1/2 study of tremelimumab (MDX-010) in patients with metastatic hormone-refractory p…
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Urology Database for Outcomes Research
This update notes the completion of the Urology Database for Outcomes Research trial, led by Kenneth Peters, MD. It covers prostate cancer, …
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel [Phase 2]
Phase 2 trial evaluating carboplatin, everolimus, and prednisone in metastatic prostate cancer post-docetaxel; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel [NA]
A completed clinical trial evaluating the combination of satraplatin and bevacizumab in metastatic prostate cancer previously treated with d…
-
CLINICAL_TRIALS research · 2014-08-22Clinical Trial Update: Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening [NA]
A completed clinical trial evaluating a decision aid intended to improve shared decision making for prostate cancer screening.
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating docetaxel with rapid hormonal cycling for prostate cancer; completed with posted results in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values [NA]
This completed trial compared MRI-guided biopsy with transrectal ultrasound-guided biopsy in men with elevated PSA to assess diagnostic appr…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Fulvestrant in Hormone Refractory Prostate Cancer [Phase 2]
This Phase 2 trial from Stanford evaluated fulvestrant in hormone-refractory prostate cancer; the study is completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA [Phase 2]
Phase 2 trial of neoadjuvant chemohormonal therapy followed by salvage surgery for high-risk prostate cancer; study terminated with results …
-
CLINICAL_TRIALS research · 2014-07-31Clinical Trial Update: Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients [NA]
This clinical trial update describes research into decision-making in unaffected first-degree relatives of prostate cancer patients; the stu…
-
CLINICAL_TRIALS research · 2014-07-30Clinical Trial Update: The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study [NA]
This clinical trial update describes a feasibility study evaluating the use of rectal balloons during radical pelvic radiotherapy for prosta…
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of Leuvectin for locally recurrent prostate cancer has been terminated.
-
CLINICAL_TRIALS withdrawal · 2014-07-29Clinical Trial Update: Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer [NA]
A clinical trial evaluating imaging during surgery to diagnose prostate, bladder, or kidney cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer [Phase 2]
A Phase 2 trial of Leuvectin followed by surgery in patients with Stage II or Stage III prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating docetaxel and prednisone with or without vaccine therapy in metastatic hormone-resistant prostate cancer; the study…
-
CLINICAL_TRIALS withdrawal · 2014-07-23Clinical Trial Update: Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]
Phase Ib/II trial evaluating orteronel with itraconazole in men with castration-resistant prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC) [Phase 1]
Phase 1 study evaluating the combination of imatinib mesylate (Gleevec) and sorafenib in androgen-independent prostate cancer has completed …
-
FDA approval · 2014-07-18FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approves a supplemental application for VABRINTY (leuprolide acetate) submitted by Uronova Pharmaceuticals, Inc. The approval updates th…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation
A completed clinical trial study assessing how geography influences the stage of prostate cancer at the start of hormonal therapy.